首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1577003

動物保健市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Animal Healthcare Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月02日 | 出版商:

Global Market Insights Inc. | 英文 235 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球動物保健市場價值為 1,861 億美元，預計 2024 年至 2032 年複合年成長率為 6%。根據世界動物基金會的數據，全球有近3.73億隻寵物貓和4.71億隻寵物狗。人畜共通傳染病的增加以及人們對動物健康重要性的認知不斷提高，正在推動對預防性保健產品和服務的需求。

動物中肥胖、糖尿病和癌症等慢性疾病的流行增加了對先進獸醫診斷和治療的需求。美國獸醫協會 (AVMA) 報告稱，大約四分之一的狗會罹患腫瘤，10 歲以上的狗中近一半會罹患癌症。

整個產業分為產品、動物類型、配銷通路和地區。

市場依產品分為藥品、醫療器材及獸醫服務。 2023年，獸醫服務佔最高市場佔有率，達75.9%。獸醫服務包括預防保健、診斷、治療、手術、牙科護理和緊急服務。它們還包括美容和日托服務。人畜共通傳染病盛行率的上升以及為確保食品安全而對牲畜進行預防性醫療保健的需求正在推動該領域的成長。

動物保健市場依動物類型分為伴侶動物和家畜動物。伴侶動物細分市場在 2023 年創造了最高收入，達到 1,132 億美元，預計在 2024 年至 2032 年期間將大幅成長。這部分包括狗、貓、馬和其他伴侶動物。寵物人性化的趨勢，即寵物被視為家庭成員，正在推動其醫療保健需求的支出增加。寵物擁有量的增加、可支配收入的增加以及獸醫醫療保健服務的進步進一步促進了該細分市場的成長。

北美動物保健產業在 2023 年佔最大佔有率，達到 38.9%，預計在預測期內複合年成長率為 5.5%。強勁的市場佔有率歸因於其完善的獸醫醫療保健基礎設施、高寵物收養率、大量牲畜數量以及對動物健康和保健的日益關注。可支配收入水準的提高導致寵物保健產品和服務的支出增加，進一步推動市場成長。主要市場參與者的存在以及獸醫診斷和治療領域持續的技術進步也可能有助於在動物保健行業中佔據主導地位。

產業生態系統分析
產業影響力
- 成長動力
  - 寵物數量不斷增加
  - 政府和公共組織加強對動物照護的支持
  - 對網路獸藥局的需求不斷成長
  - 動物保健支出增加
- 產業陷阱與挑戰
  - 與動物保健藥物相關的高成本
  - 農村地區的准入有限
成長潛力分析
監管環境
- 北美洲
  - 美國
  - 加拿大
- 歐洲聯盟
- 亞太地區
  - 日本
  - 中國
技術景觀
報銷場景
動物保健產業的創投場景
動物保健產業的經濟影響
差距分析
消費者行為趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2018 - 2032 年

主要趨勢
藥品
- 藥品
  - 抗寄生蟲藥
  - 消炎劑
  - 抗感染藥
  - 其他藥品
- 疫苗
  - 改良活疫苗 (MLV)
  - 去活化去活化疫苗
  - 其他疫苗
- 藥用飼料添加劑
  - 抗生素
  - 維生素
  - 胺基酸
  - 酵素
  - 抗氧化劑
  - 益生元和益生菌
  - 礦物質
  - 其他藥物飼料添加劑
醫療器材
- 獸醫診斷設備
- 獸醫麻醉設備
- 獸醫病人監護設備
- 獸醫手術設備
- 獸醫耗材
- 其他醫療器材
獸醫服務

第 6 章：市場估計與預測：按動物類型，2018 - 2032

主要趨勢
伴侶動物
- 狗
- 貓
- 馬匹
- 其他伴侶動物
畜牧動物
- 家禽
- 豬
- 牛
- 魚
- 其他家畜動物

第 7 章：市場估計與預測：按配銷通路，2018 年 - 2032 年

主要趨勢
獸醫院藥房
電子商務
零售藥房

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 波蘭
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 台灣
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 海灣合作理事會國家
- 以色列
- 中東和非洲其他地區

第 9 章：公司簡介

B. Braun Vet Care (B Braun Melsungen AG)
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Dechra Pharmaceuticals
Elanco Animal Health
Endovac Animal Health
HIPRA
IDEXX Laboratories
Merck and Co
Medtronic plc
Neogen Corporation
Sklar Surgical Instruments
Symrise
Vetoquinol SA
Virbac SA
Zoetis, Inc.

簡介目錄

Product Code: 735

The Global Animal Healthcare Market was valued at USD 186.1 billion in 2023 and is projected to grow at a CAGR of 6% from 2024 to 2032. Increasing pet ownership rates are driving higher spending on pet healthcare. According to the World Animal Foundation, there are nearly 373 million pet cats and 471 million pet dogs globally. The rise in zoonotic diseases and growing awareness of animal health importance are boosting demand for preventive healthcare products and services.

The prevalence of chronic diseases in animals, such as obesity, diabetes, and cancer, is increasing the need for advanced veterinary diagnostics and therapeutics. The American Veterinary Medical Association (AVMA) reports that approximately 1 in 4 dogs will develop neoplasia, and nearly half of dogs over 10 years old will develop cancer.

The overall industry is divided into product, animal type, distribution channel, and region.

The market is segmented by product into pharmaceuticals, medical devices, and veterinary services. In 2023, veterinary services held the highest market share at 75.9%. Veterinary services encompass preventive care, diagnostics, treatments, surgeries, dental care, and emergency services. They also include grooming and day-care services. The rising prevalence of zoonotic diseases and the need for preventive healthcare in livestock to ensure food safety are driving this segment's growth.

The animal healthcare market is classified by animal type into companion animals and livestock animals. The companion animals segment generated the highest revenue of USD 113.2 billion in 2023 and is expected to grow significantly during 2024-2032. This segment includes dogs, cats, horses, and other companion animals. The trend of pet humanization, where pets are treated as family members, is driving higher spending on their healthcare needs. Increasing pet ownership, rising disposable incomes, and advancements in veterinary healthcare services are further contributing to segment growth.

North America animal healthcare industry held the largest share at 38.9% in 2023 and is anticipated to grow at a 5.5% CAGR over the forecast period. The strong market share is due to its well-established veterinary healthcare infrastructure, high pet adoption rates, large livestock population, and a growing focus on animal health and wellness. Increased disposable income levels have led to higher spending on pet healthcare products and services, further driving market growth. The presence of key market players and ongoing technological advancements in veterinary diagnostics and therapeutics may also contribute to dominance in the animal healthcare industry.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing population of pet animals
  - 3.2.1.2 Increasing support offered by government and public organizations for animal care
  - 3.2.1.3 Growing demand for online veterinary pharmacies
  - 3.2.1.4 Increase in animal healthcare expenditure
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost associated with animal health drugs
  - 3.2.2.2 Limited access in rural areas
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 North America
  - 3.4.1.1 U.S.
  - 3.4.1.2 Canada
- 3.4.2 European Union
- 3.4.3 Asia Pacific
  - 3.4.3.1 Japan
  - 3.4.3.2 China
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Venture capitalist scenario in animal health industry
3.8 Economic impacts of the animal health industry
3.9 Gap analysis
3.10 Consumer behaviour trends
3.11 Porter's analysis
3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Pharmaceuticals
- 5.2.1 Drugs
  - 5.2.1.1 Antiparasitic
  - 5.2.1.2 Anti-inflammatory
  - 5.2.1.3 Anti-infectives
  - 5.2.1.4 Other drugs
- 5.2.2 Vaccines
  - 5.2.2.1 Modified live vaccines (MLV)
  - 5.2.2.2 Killed inactivated vaccines
  - 5.2.2.3 Other vaccines
- 5.2.3 Medicated feed additives
  - 5.2.3.1 Antibiotics
  - 5.2.3.2 Vitamins
  - 5.2.3.3 Amino acids
  - 5.2.3.4 Enzymes
  - 5.2.3.5 Antioxidants
  - 5.2.3.6 Prebiotics and probiotics
  - 5.2.3.7 Minerals
  - 5.2.3.8 Other medicated feed additives
5.3 Medical devices
- 5.3.1 Veterinary diagnostic equipment
- 5.3.2 Veterinary anesthesia equipment
- 5.3.3 Veterinary patient monitoring equipment
- 5.3.4 Veterinary surgical equipment
- 5.3.5 Veterinary consumables
- 5.3.6 Other medical devices
5.4 Veterinary services

Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Companion animals
- 6.2.1 Dogs
- 6.2.2 Cats
- 6.2.3 Horses
- 6.2.4 Other companion animals
6.3 Livestock animals
- 6.3.1 Poultry
- 6.3.2 Swine
- 6.3.3 Cattle
- 6.3.4 Fish
- 6.3.5 Other livestock animals

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Veterinary hospital pharmacy
7.3 E-commerce
7.4 Retail pharmacy

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Poland
- 8.3.7 Netherlands
- 8.3.8 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Taiwan
- 8.4.7 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 GCC Countries
- 8.6.3 Israel
- 8.6.4 Rest of Middle East and Africa